Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Acrivon Therapeutics (ACRV): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Market Outperform
11 analysts
Options Flow (P/C)
—
Avg Consensus PT
$17
+978.9%
Highest Price Target
$30
+1779.7%
Lowest Price Target
$8
+401.3%
Short Interest
6.3%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Citizens | Silvan Turkcan— | +714.5% | $13 → $13 | Maintained | Market Outperform |
| Jan 9, 2026 | Piper Sandler | Edward Tenthoff— | +401.3% | $6 → $8 | Maintained | Overweight |